FDA Inspection 1324132 — Sherif M. El-Harazi, M.D., MPH
The FDA completed an inspection of Sherif M. El-Harazi, M.D., MPH on Jun 18, 2026 in Glendale, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 18, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Glendale, CA (United States)
Additional Details
Clinical Investigator (CI)